ReviewTherapeutic advances in hematology2022

Current options and future perspectives in the treatment of patients with relapsed/refractory diffuse large B-cell lymphoma.

Fabian Frontzek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.